濮阳东方看男科咨询(濮阳东方医院妇科做人流评价非常好) (今日更新中)

A Kentucky high school teacher on Tuesday ousted an incumbent state lawmaker who had a role in passing a controversial pension bill this year that sparked outrage from teachers across the state.Republican voters chose Travis Brenda, a high school math teacher, over House Majority Floor Leader Jonathan Shell, who was first elected in 2012.Brenda bested Shell by a narrow margin of 123 votes In Tuesday's Republican primary for House District 71st, according to unofficial results posted to the Kentucky State Board of Elections.This past spring, Kentucky teachers held rallies at the state Capitol for more funding and to oppose a controversial pension bill, Senate Bill 151, which, among other initiatives, prevents changes to annual cost-of-living adjustments and limits the number of sick days teachers can put toward their retirement.Shell had helped turn SB 151, which had been about sewage services, into a pension overhaul and voted in support of the bill. The bill was quickly passed in the House and the Senate without allowing the public to read it, and then sent to GOP Gov. Matt Bevin to sign the bill on April 11.During the campaign, Brenda used his experience as a teacher to make the point that he's not a politician and he understands the importance of funding education. On Twitter, Brenda was critical of the pension bill and posted pictures from the April 2 teacher protest at the state Capitol.Shell confirmed to CNN he called Brenda Tuesday night to congratulate him. Shell, once considered a rising star in Kentucky Republican politics, said he was grateful for the six years he served and now looks forward to spending more time with his wife and kids.Brenda will go on to face Democratic candidate Mary Renfro in November's general election. 1774

A faulty engine part that could cause vehicles to stall has led to a recall of 400,000 worldwide.The recall affects Toyota Motor Corp. and Subaru Corp., MarketWatch reports. About 80,000 of the 400,000 are Toyotas.Subaru is recalling some of its most popular models, such as the Forester sport-utility vehicle and Impreza and BRZ sports car. Toyota is recalling the Subaru-made 86 and Scion FR-S sports car, MarketWatch said.The automakers announced springs in the engine valve could fracture. That would cause the vehicles to stall and possibly lead to an accident.Earlier in October, Toyota recalled approximately 2.4 million vehicles worldwide due to a problem in which the cars may not enter a fail-safe driving mode as intended, which can cause the vehicle to lose power and stall. About 807,000 of those vehicles are in the United States. If this happens while driving at higher speeds, it could cause a crash. The recall affects 2010-2014 model year Toyota Prius and 2012-2014 Prius v vehicles.There was a second recall involving certain 2018-2019 Tundra and Sequoia vehicles and 2019 Avalon vehicles. About 168,000 vehicles sold in the United States are affected by this recall, which is due to a programming problem in the airbag electronic control unit (ECU) that could disable one or more of the sensors used to detect crashes, possibly causing the side and curtain shield airbags and/or front and knee airbags to not deploy as intended.  1502

A federal judge has reportedly thrown out President Trump’s latest effort to block the Manhattan district attorney from subpoenaing his financial records, according to multiple outlets.President Trump’s lawyers made their final arguments to block the prosecutor from getting his tax records on August 10. U.S. District Judge Victor Marrero issued his ruling Thursday.The same judge refused to throw out the subpoena last year. Then this summer, the U.S. Supreme Court essentially upheld his decision when they returned the case to the lower level, saying Trump’s lawyers were entitled to challenge the subpoena in the same manner as anyone else.District Attorney Cyrus Vance says his investigation into Trump’s business practices is entitled to extensive records to aid a “complex financial investigation” and they cited in their papers public reports of “extensive and protracted criminal conduct at the Trump Organization.” He is seeking eight years of Trump’s personal and business tax returns. 1005

A growing number of members of Congress are fearing for their own safety and they are being threatened at an alarming rate.After nearly being assassinated while at a baseball practice last year with other Republicans, Congressman Steve Scalise found himself the target of another threat this month. Authorities arrested a man, after he left threatening voicemails for Scalise. Investigators said they found 200 rounds of ammunition and books on homemade explosives at the man’s home, along with receipts for an assault rifle and a handgun, according to court records.“Hopefully he gets a serious sentence, because you can’t allow this kind of threats and violence against people based on their political views,” Scalise said during an interview on Fox News.Arizona Congressman David Schweikert has served in Congress since 2010. He said he and his family are dealing with a growing number of threats.“We had more death threats last year in my office--even one towards my little girl--than we ever had in all of the other years combined,” Schweikert said during an interview on “Plaidcast,” a podcast hosted by Rep. Sean Duffy.In June, California congresswoman Maxine Waters canceled events in Alabama and Texas, after she said she received a “very serious death threat.”According to the House Sergeant of Arms Office, the number of threats against members of Congress are skyrocketing. So far this year, the office said there have been more than 1,600 threats against members of the House alone. Last year, there were nearly 2,000 reported incidents and 902 in 2016.For the past two years, the committee that oversees security for House members, allocated ,000 for security to each of the 435 members of the House of Representatives. Some House members have bought body armor, hired armed security guards or beefed up security at their offices.The Senate Sergeant at Arms Office said it does not release data pertaining to threats to U.S. senators.  1970

A final analysis of a COVID-19 vaccine candidate produced by Pfizer and BioNTech shows that the drug is 95% effective in preventing the coronavirus, and the companies say they hope to apply for Emergency Use Authorization within "days," the company reported Wednesday.The announcement is an improvement from an initial analysis released by the company just over a week ago that showed the drug to be 90% effective. Those results were released when it had been confirmed that 94 participants in the trial who received a shot had contracted COVID-19, and only 10% of those participants who contracted the virus had actually received the vaccine. Updated information now shows that 170 people who participated in the trial have contracted COVID-19, which crosses the threshold for final analysis. Of those participants, 162 received a placebo shot. Of the 20,000 participants who received the vaccine, just one has developed a severe case of COVID-19. The other seven people who received the vaccine and caught the virus are only experiencing mild symptoms.Pfizer also added that the vaccine has proven to be 94% efficient in older people — a welcome sign, given that the virus tends to present more severe symptoms in elderly patients.Pfizer's trial included about 40,000 participants, half of which received the vaccine, and the other half which received the placebo. The vaccine requires two shots, which need to be taken 28 days apart.The company added that there have been no safety concerns with the vaccine. In a randomized survey of 8,000 participants, only 2% reported suffering severe fatigue, and only 4% reported suffering severe headaches. Those who say they suffered side effects only experienced them briefly after vaccination.Wednesday's announcement means Pfizer is on track to shatter records for vaccine development, a process that typically takes several years.Pfizer and BioNTech already have their vaccine candidate in production, meaning it will be ready for distribution as soon as the Food and Drug Administration grants Emergency Use Authorization.Pfizer's announcement comes days after an initial analysis of a Moderna-produced vaccine was also shown to be 95% effective. Several other companies also have a COVID-19 vaccine in the works, something that health officials say is important for logistics and safety. 2347

来源：资阳报